Skip to main content Accessibility help

Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder

  • R. C. Kessler (a1), H. M. van Loo (a2), K. J. Wardenaar (a2), R. M. Bossarte (a3), L. A. Brenner (a4), D. D Ebert (a1) (a5), P. de Jonge (a2), A. A. Nierenberg (a6), A. J. Rosellini (a1), N. A. Sampson (a1), R. A. Schoevers (a2), M. A. Wilcox (a7) and A. M. Zaslavsky (a1)...



Clinicians need guidance to address the heterogeneity of treatment responses of patients with major depressive disorder (MDD). While prediction schemes based on symptom clustering and biomarkers have so far not yielded results of sufficient strength to inform clinical decision-making, prediction schemes based on big data predictive analytic models might be more practically useful.


We review evidence suggesting that prediction equations based on symptoms and other easily-assessed clinical features found in previous research to predict MDD treatment outcomes might provide a foundation for developing predictive analytic clinical decision support models that could help clinicians select optimal (personalised) MDD treatments. These methods could also be useful in targeting patient subsamples for more expensive biomarker assessments.


Approximately two dozen baseline variables obtained from medical records or patient reports have been found repeatedly in MDD treatment trials to predict overall treatment outcomes (i.e., intervention v. control) or differential treatment outcomes (i.e., intervention A v. intervention B). Similar evidence has been found in observational studies of MDD persistence-severity. However, no treatment studies have yet attempted to develop treatment outcome equations using the full set of these predictors. Promising preliminary empirical results coupled with recent developments in statistical methodology suggest that models could be developed to provide useful clinical decision support in personalised treatment selection. These tools could also provide a strong foundation to increase statistical power in focused studies of biomarkers and MDD heterogeneity of treatment response in subsequent controlled trials.


Coordinated efforts are needed to develop a protocol for systematically collecting information about established predictors of heterogeneity of MDD treatment response in large observational treatment studies, applying and refining these models in subsequent pragmatic trials, carrying out pooled secondary analyses to extract the maximum amount of information from these coordinated studies, and using this information to focus future discovery efforts in the segment of the patient population in which continued uncertainty about treatment response exists.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder
      Available formats


Corresponding author

* Address for correspondence: Dr R. C. Kessler, Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02115, USA. (Email:


Hide All
Agid, O, Lerer, B (2003). Algorithm-based treatment of major depression in an outpatient clinic: clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation. The International Journal of Neuropsychopharmacology/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum 6, 4149.
Altshuler, LL, Cohen, LS, Moline, ML, Kahn, DA, Carpenter, D, Docherty, JP, Ross, RW (2001). Treatment of depression in women: a summary of the expert consensus guidelines. Journal of Psychiatric Practice 7, 185208.
American Psychiatric Association (2010). Practice Guideline for the Treatment of Patients with Major Depressive Disorder. American Psychiatric Association: Arlington, VA.
Andreasen, NC, Grove, WM (1982). The classification of depression: traditional versus mathematical approaches. The American Journal of Psychiatry 139, 4552.
Andreescu, C, Lenze, EJ, Dew, MA, Begley, AE, Mulsant, BH, Dombrovski, AY, Pollock, BG, Stack, J, Miller, MD, Reynolds, CF (2007). Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study. The British Journal of Psychiatry: The Journal of Mental Science 190, 344349.
Andreescu, C, Chang, CC, Mulsant, BH, Ganguli, M (2008 a). Twelve-year depressive symptom trajectories and their predictors in a community sample of older adults. International Psychogeriatrics/IPA 20, 221236.
Andreescu, C, Mulsant, BH, Houck, PR, Whyte, EM, Mazumdar, S, Dombrovski, AY, Pollock, BG, Reynolds, CF III (2008 b). Empirically derived decision trees for the treatment of late-life depression. The American Journal of Psychiatry 165, 855862.
Anglemyer, A, Horvath, HT, Bero, L (2014). Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. The Cochrane Database of Systematic Reviews 4, MR000034.
Angst, J, Gamma, A, Rossler, W, Ajdacic, V, Klein, DN (2011). Childhood adversity and chronicity of mood disorders. European Archives of Psychiatry and Clinical Neuroscience 261, 2127.
Anothaisintawee, T, Teerawattananon, Y, Wiratkapun, C, Kasamesup, V, Thakkinstian, A (2012). Risk prediction models of breast cancer: a systematic review of model performances. Breast Cancer Research and Treatment 133, 110.
Bagby, RM, Quilty, LC, Segal, ZV, McBride, CC, Kennedy, SH, Costa, PT (2008). Personality and differential treatment response in major depression: a randomized controlled trial comparing cognitive-behavioural therapy and pharmacotherapy. Canadian Journal of Psychiatry/Revue Canadienne de Psychiatrie 53, 361370.
Barber, JP, Muenz, LR (1996). The role of avoidance and obsessiveness in matching patients to cognitive and interpersonal psychotherapy: empirical findings from the treatment for depression collaborative research program. Journal of Consulting and Clinical Psychology 64, 951958.
Baumeister, H, Gordon, P (2012). Meta-review of depressive subtyping models. Journal of Affective Disorders 139, 126140.
Bellino, S, Paradiso, E, Bogetto, F (2008). Efficacy and tolerability of pharmacotherapies for borderline personality disorder. CNS Drugs 22, 671692.
Bernecker, SL, Constantino, MJ, Pazzaglia, AM, Ravitz, P, McBride, C (2014). Patient interpersonal and cognitive changes and their relation to outcome in interpersonal psychotherapy for depression. Journal of Clinical Psychology 70, 518527.
Bradvik, L, Mattisson, C, Bogren, M, Nettelbladt, P (2008). Long-term suicide risk of depression in the Lundby cohort 1947–1997 – severity and gender. Acta Psychiatrica Scandinavica 117, 185191.
Breitenstein, B, Scheuer, S, Holsboer, F (2014). Are there meaningful biomarkers of treatment response for depression? Drug Discovery Today 19, 539561.
Burke, JF, Hayward, RA, Nelson, JP, Kent, DM (2014). Using internally developed risk models to assess heterogeneity in treatment effects in clinical trials. Circulation: Cardiovascular Quality and Outcomes 7, 163169.
Carter, JD, Luty, SE, McKenzie, JM, Mulder, RT, Frampton, CM, Joyce, PR (2011). Patient predictors of response to cognitive behaviour therapy and interpersonal psychotherapy in a randomised clinical trial for depression. Journal of Affective Disorders 128, 252261.
Chang, YJ, Chen, LJ, Chung, KP, Lai, MS (2012). Risk groups defined by Recursive Partitioning Analysis of patients with colorectal adenocarcinoma treated with colorectal resection. BMC Medical Research Methodology 12, 2.
Chao, ST, Koyfman, SA, Woody, N, Angelov, L, Soeder, SL, Reddy, CA, Rybicki, LA, Djemil, T, Suh, JH (2012). Recursive partitioning analysis index is predictive for overall survival in patients undergoing spine stereotactic body radiation therapy for spinal metastases. International Journal of Radiation Oncology, Biology, Physics 82, 17381743.
Cohen, A, Houck, PR, Szanto, K, Dew, MA, Gilman, SE, Reynolds, CF (2006). Social inequalities in response to antidepressant treatment in older adults. Archives of General Psychiatry 63, 5056.
Cohen, A, Gilman, SE, Houck, PR, Szanto, K, Reynolds, CF (2009). Socioeconomic status and anxiety as predictors of antidepressant treatment response and suicidal ideation in older adults. Social Psychiatry and Psychiatric Epidemiology 44, 272277.
Constantino, MJ, Adams, ML, Pazzaglia, AM, Bernecker, SL, Ravitz, P, McBride, C (2013). Baseline patient characteristics as predictors of remission in interpersonal psychotherapy for depression. Psychotherapy Research: Journal of the Society for Psychotherapy Research 23, 190200.
Cooper, C, Jones, L, Dunn, E, Forty, L, Haque, S, Oyebode, F, Craddock, N, Jones, I (2007). Clinical presentation of postnatal and non-postnatal depressive episodes. Psychological Medicine 37, 12731280.
Cooper, PJ, Murray, L (1995). Course and recurrence of postnatal depression. Evidence for the specificity of the diagnostic concept. The British Journal of Psychiatry: The Journal of Mental Science 166, 191195.
Cronkite, RC, Woodhead, EL, Finlay, A, Timko, C, Unger Hu, K, Moos, RH (2013). Life stressors and resources and the 23-year course of depression. Journal of Affective Disorders 150, 370377.
Cuijpers, P, Reynolds, CF III, Donker, T, Li, J, Andersson, G, Beekman, A (2012). Personalized treatment of adult depression: medication, psychotherapy, or both? A systematic review. Depression and Anxiety 29, 855864.
Demyttenaere, K, Bruffaerts, R, Posada-Villa, J, Gasquet, I, Kovess, V, Lepine, JP, Angermeyer, MC, Bernert, S, de Girolamo, G, Morosini, P, Polidori, G, Kikkawa, T, Kawakami, N, Ono, Y, Takeshima, T, Uda, H, Karam, EG, Fayyad, JA, Karam, AN, Mneimneh, ZN, Medina-Mora, ME, Borges, G, Lara, C, de Graaf, R, Ormel, J, Gureje, O, Shen, Y, Huang, Y, Zhang, M, Alonso, J, Haro, JM, Vilagut, G, Bromet, EJ, Gluzman, S, Webb, C, Kessler, RC, Merikangas, KR, Anthony, JC, Von Korff, MR, Wang, PS, Brugha, TS, Aguilar-Gaxiola, S, Lee, S, Heeringa, S, Pennell, BE, Zaslavsky, AM, Ustun, TB, Chatterji, S (2004). Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 291, 25812590.
Denton, WH, Carmody, TJ, Rush, AJ, Thase, ME, Trivedi, MH, Arnow, BA, Klein, DN, Keller, MB (2010). Dyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depression. Psychological Medicine 40, 415424.
DeRubeis, RJ, Cohen, ZD, Forand, NR, Fournier, JC, Gelfand, LA, Lorenzo-Luaces, L (2014). The Personalized Advantage Index: translating research on prediction into individualized treatment recommendations. A demonstration. PloS ONE 9, e83875.
Dew, MA, Reynolds, CF III, Houck, PR, Hall, M, Buysse, DJ, Frank, E, Kupfer, DJ (1997). Temporal profiles of the course of depression during treatment. Predictors of pathways toward recovery in the elderly. Archives of General Psychiatry 54, 10161024.
Diaz Munoz, I, van der Laan, MJ (2011). Super learner based conditional density estimation with application to marginal structural models. The International Journal of Biostatistics 7, Article 38.
Dimidjian, S, Hollon, SD, Dobson, KS, Schmaling, KB, Kohlenberg, RJ, Addis, ME, Gallop, R, McGlinchey, JB, Markley, DK, Gollan, JK, Atkins, DC, Dunner, DL, Jacobson, NS (2006). Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. Journal of Consulting and Clinical Psychology 74, 658670.
Dorresteijn, JA, Visseren, FL, Ridker, PM, Wassink, AM, Paynter, NP, Steyerberg, EW, van der Graaf, Y, Cook, NR (2011). Estimating treatment effects for individual patients based on the results of randomised clinical trials. BMJ 343, d5888.
Dunlop, BW, Binder, EB, Cubells, JF, Goodman, MM, Kelley, ME, Kinkead, B, Kutner, M, Nemeroff, CB, Newport, DJ, Owens, MJ, Pace, TW, Ritchie, JC, Rivera, VA, Westen, D, Craighead, WE, Mayberg, HS (2012). Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial. Trials 13, 106.
Eaton, WW, Shao, H, Nestadt, G, Lee, HB, Bienvenu, OJ, Zandi, P (2008). Population-based study of first onset and chronicity in major depressive disorder. Archives of General Psychiatry 65, 513520.
Echouffo-Tcheugui, JB, Kengne, AP (2013). Comparative performance of diabetes-specific and general population-based cardiovascular risk assessment models in people with diabetes mellitus. Diabetes & Metabolism 39, 389396.
Elkin, I, Shea, MT, Watkins, JT, Imber, SD, Sotsky, SM, Collins, JF, Glass, DR, Pilkonis, PA, Leber, WR, Docherty, JP, Fiester, SJ, Parloff, MB (1989). National institute of mental health treatment of depression collaborative research program. General effectiveness of treatments. Archives of General Psychiatry 46, 971982; discussion 983.
Feske, U, Frank, E, Kupfer, DJ, Shear, MK, Weaver, E (1998). Anxiety as a predictor of response to interpersonal psychotherapy for recurrent major depression: an exploratory investigation. Depression and Anxiety 8, 135141.
Fichter, MM, Quadflieg, N, Fischer, UC, Kohlboeck, G (2010). Twenty-five-year course and outcome in anxiety and depression in the Upper Bavarian Longitudinal Community Study. Acta Psychiatrica Scandinavica 122, 7585.
Fink, M, Rush, AJ, Knapp, R, Rasmussen, K, Mueller, M, Rummans, TA, O'Connor, K, Husain, M, Biggs, M, Bailine, S, Kellner, CH (2007). DSM melancholic features are unreliable predictors of ECT response: a CORE publication. The Journal of ECT 23, 139146.
Fournier, JC, DeRubeis, RJ, Shelton, RC, Gallop, R, Amsterdam, JD, Hollon, SD (2008). Antidepressant medications v. cognitive therapy in people with depression with or without personality disorder. The British Journal of Psychiatry: The Journal of Mental Science 192, 124129.
Fournier, JC, DeRubeis, RJ, Shelton, RC, Hollon, SD, Amsterdam, JD, Gallop, R (2009). Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. Journal of Consulting and Clinical Psychology 77, 775787.
Frank, E, Cassano, GB, Rucci, P, Thompson, WK, Kraemer, HC, Fagiolini, A, Maggi, L, Kupfer, DJ, Shear, MK, Houck, PR, Calugi, S, Grochocinski, VJ, Scocco, P, Buttenfield, J, Forgione, RN (2011). Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy. Psychological Medicine 41, 151162.
Hastie, T, Tibshirani, R, Friedman, J (2009). The Elements of Statistical Learning: Data Mining, Inference, and Prediction, 2nd edn. Springer: New York.
Hayward, RA, Kent, DM, Vijan, S, Hofer, TP (2006). Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis. BMC Medical Research Methodology 6, 18.
Hetrick, SE, Simmons, M, Thompson, A, Parker, AG (2011). What are specialist mental health clinician attitudes to guideline recommendations for the treatment of depression in young people? The Australian and New Zealand Journal of Psychiatry 45, 9931001.
Hoencamp, E, Haffmans, PM, Duivenvoorden, H, Knegtering, H, Dijken, WA (1994). Predictors of (non-) response in depressed outpatients treated with a three-phase sequential medication strategy. Journal of Affective Disorders 31, 235246.
Hollon, SD, DeRubeis, RJ, Fawcett, J, Amsterdam, JD, Shelton, RC, Zajecka, J, Young, PR, Gallop, R (2014). Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry 71, 11571164.
Huibers, MJH, Cohen, ZD, Lemmens, LHJM, Arntz, A, Peeters, FPML, Cuijpers, P, DeRubeis, RJ (2015). Predicting optimal outcomes in cognitive therapy or interpersonal psychotherapy for depressed individuals using the personalized advantage index approach. PLoS ONE 10, e0140771.
Ionescu, R, Popescu, C, Jipescu, I (1994). Predictors of outcome in depression. Romanian Journal of Neurology and Psychiatry/Revue Roumaine de Neurologie et Psychiatrie 32, 153173.
Jain, FA, Hunter, AM, Brooks, JO III, Leuchter, AF (2013). Predictive socioeconomic and clinical profiles of antidepressant response and remission. Depression and Anxiety 30, 624630.
James, G, Witten, D, Hastie, T, Tibshirani, R (2013). An Introduction to Statistical Learning: with Applications in R. Springer: New York.
Jarrett, RB, Minhajuddin, A, Kangas, JL, Friedman, ES, Callan, JA, Thase, ME (2013). Acute phase cognitive therapy for recurrent major depressive disorder: who drops out and how much do patient skills influence response? Behaviour Research and Therapy 51, 221230.
Johnstone, JM, Luty, SE, Carter, JD, Mulder, RT, Frampton, CM, Joyce, PR (2009). Childhood neglect and abuse as predictors of antidepressant response in adult depression. Depression and Anxiety 26, 711717.
Joyce, PR, McKenzie, JM, Carter, JD, Rae, AM, Luty, SE, Frampton, CM, Mulder, RT (2007). Temperament, character and personality disorders as predictors of response to interpersonal psychotherapy and cognitive-behavioural therapy for depression. The British Journal of Psychiatry: The Journal of Mental Science 190, 503508.
Kennedy, SH, Andersen, HF, Lam, RW (2006). Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis. Journal of Psychiatry & Neuroscience 31, 122131.
Kennedy, SH, Downar, J, Evans, KR, Feilotter, H, Lam, RW, MacQueen, GM, Milev, R, Parikh, SV, Rotzinger, S, Soares, C (2012). The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response prediction. Current Pharmaceutical Design 18, 59765989.
Kent, DM, Rothwell, PM, Ioannidis, JP, Altman, DG, Hayward, RA (2010). Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials 11, 85.
Kessler, RC, McGonagle, KA, Zhao, S, Nelson, CB, Hughes, M, Eshleman, S, Wittchen, HU, Kendler, KS (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry 51, 819.
Kessler, RC, Merikangas, KR, Berglund, P, Eaton, WW, Koretz, DS, Walters, EE (2003). Mild disorders should not be eliminated from the DSM-V. Archives of General Psychiatry 60, 11171122.
Kessler, RC, Berglund, P, Chiu, WT, Demler, O, Heeringa, S, Hiripi, E, Jin, R, Pennell, BE, Walters, EE, Zaslavsky, A, Zheng, H (2004). The US National Comorbidity Survey Replication (NCS-R): design and field procedures. International Journal of Methods in Psychiatric Research 13, 6992.
Kessler, RC, van Loo, HM, Wardenaar, KJ, Bossarte, RM, Brenner, LA, Cai, T, Ebert, DD, Hwang, I, Li, J, de Jonge, P, Nierenberg, AA, Petukhova, MV, Rosellini, AJ, Sampson, NA, Schoevers, RA, Wilcox, MA, Zaslavsky, AM (2016). Testing a machine-learning algorithm to predict the persistence and severity of major depressive disorder from baseline self-reports. Molecular Psychiatry.
Klein, DN, Shankman, SA, Rose, S (2008). Dysthymic disorder and double depression: prediction of 10-year course trajectories and outcomes. Journal of Psychiatric Research 42, 408415.
Kool, S, Schoevers, R, de Maat, S, Van, R, Molenaar, P, Vink, A, Dekker, J (2005). Efficacy of pharmacotherapy in depressed patients with and without personality disorders: a systematic review and meta-analysis. Journal of Affective Disorders 88, 269278.
Kraemer, HC (2013). Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: a parametric approach. Statistics in Medicine 32, 19641973.
Kuiper, S, McLean, L, Fritz, K, Lampe, L, Malhi, GS (2013). Getting depression clinical practice guidelines right: time for change? Acta Psychiatrica Scandinavica. Supplementum 2430.
Lamers, F, Burstein, M, He, JP, Avenevoli, S, Angst, J, Merikangas, KR (2012). Structure of major depressive disorder in adolescents and adults in the US general population. The British Journal of Psychiatry: The Journal of Mental Science 201, 143150.
Li, C, Lu, Y (2010). Evaluating the improvement in diagnostic utility from adding new predictors. Biometrical Journal. Biometrische Zeitschrift 52, 417435.
Lin, HW, Chen, YH (2014). Adjustment for missing confounders in studies based on observational databases: 2-stage calibration combining propensity scores from primary and validation data. American Journal of Epidemiology 180, 308317.
Liu, Y, Nie, Z, Zhou, J, Farnum, M, Narayan, VA, Wittenberg, G, Ye, J (2014). Sparse generalized functional linear model for predicting remission status of depression patients. Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 364375.
Lowe, B, Schenkel, I, Bair, MJ, Gobel, C (2005). Efficacy, predictors of therapy response, and safety of sertraline in routine clinical practice: prospective, open-label, non-interventional postmarketing surveillance study in 1878 patients. Journal of Affective Disorders 87, 271279.
Lurie, JD, Morgan, TS (2013). Pros and cons of pragmatic clinical trials. Journal of Comparative Effectiveness Research 2, 5358.
Luty, SE, Carter, JD, McKenzie, JM, Rae, AM, Frampton, CM, Mulder, RT, Joyce, PR (2007). Randomised controlled trial of interpersonal psychotherapy and cognitive-behavioural therapy for depression. The British Journal of Psychiatry: The Journal of Mental Science 190, 496502.
Madigan, CD, Jolly, K, Lewis, AL, Aveyard, P, Daley, AJ (2014). A randomised controlled trial of the effectiveness of self-weighing as a weight loss intervention. The International Journal of Behavioral Nutrition and Physical Activity 11, 125.
Marquett, RM, Thompson, LW, Reiser, RP, Holland, JM, O'Hara, RM, Kesler, SR, Stepanenko, A, Bilbrey, A, Rengifo, J, Majoros, A, Thompson, DG (2013). Psychosocial predictors of treatment response to cognitive-behavior therapy for late-life depression: an exploratory study. Aging & Mental Health 17, 830838.
Mattisson, C, Bogren, M, Horstmann, V, Munk-Jorgensen, P, Nettelbladt, P (2007). The long-term course of depressive disorders in the Lundby Study. Psychological Medicine 37, 883891.
McBride, C, Atkinson, L, Quilty, LC, Bagby, RM (2006). Attachment as moderator of treatment outcome in major depression: a randomized control trial of interpersonal psychotherapy versus cognitive behavior therapy. Journal of Consulting and Clinical Psychology 74, 10411054.
McGrath, PJ, Nunes, EV, Stewart, JW, Goldman, D, Agosti, V, Ocepek-Welikson, K, Quitkin, FM (1996). Imipramine treatment of alcoholics with primary depression: a placebo-controlled clinical trial. Archives of General Psychiatry 53, 232240.
Moos, RH, Cronkite, RC (1999). Symptom-based predictors of a 10-year chronic course of treated depression. The Journal of Nervous and Mental Disease 187, 360368.
Mueller, TI, Leon, AC, Keller, MB, Solomon, DA, Endicott, J, Coryell, W, Warshaw, M, Maser, JD (1999). Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. The American Journal of Psychiatry 156, 10001006.
Nanni, V, Uher, R, Danese, A (2012). Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis. The American Journal of Psychiatry 169, 141151.
National Institute for Health and Clinical Excellence (NICE) (2009). Depression: Treatment and Mangement of Depression in Adult. National Institute for Health and Clinical Excellence: London.
Nelson, JC, Zhang, Q, Deberdt, W, Marangell, LB, Karamustafalioglu, O, Lipkovich, IA (2012). Predictors of remission with placebo using an integrated study database from patients with major depressive disorder. Current Medical Research and Opinion 28, 325334.
Nemeroff, CB, Heim, CM, Thase, ME, Klein, DN, Rush, AJ, Schatzberg, AF, Ninan, PT, McCullough, JP Jr., Weiss, PM, Dunner, DL, Rothbaum, BO, Kornstein, S, Keitner, G, Keller, MB (2003). Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proceedings of the National Academy of Sciences of the United States of America 100, 1429314296.
Neugebauer, R, Schmittdiel, JA, van der Laan, MJ (2014). Targeted learning in real-world comparative effectiveness research with time-varying interventions. Statistics in Medicine 33, 24802520.
Papakostas, GI, Stahl, SM, Krishen, A, Seifert, CA, Tucker, VL, Goodale, EP, Fava, M (2008). Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies. The Journal of Clinical Psychiatry 69, 12871292.
Perel, P, Edwards, P, Wentz, R, Roberts, I (2006). Systematic review of prognostic models in traumatic brain injury. BMC Medical Informatics and Decision Making 6, 38.
Perlis, RH (2007). Use of treatment guidelines in clinical decision making in bipolar disorder: a pilot survey of clinicians. Current Medical Research and Opinion 23, 467475.
Perlis, RH (2013). A clinical risk stratification tool for predicting treatment resistance in major depressive disorder. Biological Psychiatry 74, 714.
Perlis, RH (2014). Pharmacogenomic testing and personalized treatment of depression. Clinical Chemistry 60, 5359.
Picciotto, S, Eisen, EA, Chevrier, J (2014). 0351 G-estimation: why does it work and what does it offer? Occupational and Environmental Medicine 71 (Suppl. 1), A120A121.
Pizzagalli, DA (2011). Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 36, 183206.
Prentice, RL, Langer, RD, Stefanick, ML, Howard, BV, Pettinger, M, Anderson, GL, Barad, D, Curb, JD, Kotchen, J, Kuller, L, Limacher, M, Wactawski-Wende, J (2006). Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease. American Journal of Epidemiology 163, 589599.
Prieto-Merino, D, Pocock, SJ (2012). The science of risk models. European Journal of Preventive Cardiology 19, 713.
Quitkin, FM, McGrath, PJ, Stewart, JW, Harrison, W, Tricamo, E, Wager, SG, Ocepek-Welikson, K, Nunes, E, Rabkin, JG, Klein, DF (1990). Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication. Archives of General Psychiatry 47, 935941.
Quitkin, FM, Harrison, W, Stewart, JW, McGrath, PJ, Tricamo, E, Ocepek-Welikson, K, Rabkin, JG, Wager, SG, Nunes, E, Klein, DF (1991). Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design. Archives of General Psychiatry 48, 319323.
Rabinoff, M, Kitchen, CM, Cook, IA, Leuchter, AF (2011). Evaluation of quantitative EEG by classification and regression trees to characterize responders to antidepressant and placebo treatment. The Open Medical Informatics Journal 5, 18.
Riedel, M, Moller, HJ, Obermeier, M, Adli, M, Bauer, M, Kronmuller, K, Brieger, P, Laux, G, Bender, W, Heuser, I, Zeiler, J, Gaebel, W, Schennach-Wolff, R, Henkel, V, Seemuller, F (2011). Clinical predictors of response and remission in inpatients with depressive syndromes. Journal of Affective Disorders 133, 137149.
Ritchie, MD (2005). Bioinformatics approaches for detecting gene-gene and gene–environment interactions in studies of human disease. Neurosurgical Focus 19, E2.
Romera, I, Delgado-Cohen, H, Perez, T, Caballero, L, Gilaberte, I (2008). Factor analysis of the Zung self-rating depression scale in a large sample of patients with major depressive disorder in primary care. BMC Psychiatry 8, 4.
Rush, AJ, Wisniewski, SR, Warden, D, Luther, JF, Davis, LL, Fava, M, Nierenberg, AA, Trivedi, MH (2008). Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features. Archives of General Psychiatry 65, 870880.
Simon, GE, Perlis, RH (2010). Personalized medicine for depression: can we match patients with treatments? The American Journal of Psychiatry 167, 14451455.
Siontis, GC, Tzoulaki, I, Siontis, KC, Ioannidis, JP (2012). Comparisons of established risk prediction models for cardiovascular disease: systematic review. BMJ 344, e3318.
Smits, JA, Minhajuddin, A, Thase, ME, Jarrett, RB (2012). Outcomes of acute phase cognitive therapy in outpatients with anxious versus nonanxious depression. Psychotherapy and Psychosomatics 81, 153160.
Sotsky, SM, Glass, DR, Shea, MT, Pilkonis, PA, Collins, JF, Elkin, I, Watkins, JT, Imber, SD, Leber, WR, Moyer, J, et al. (1991). Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program. The American Journal of Psychiatry 148, 9971008.
Souslova, T, Marple, TC, Spiekerman, AM, Mohammad, AA (2013). Personalized medicine in Alzheimer's disease and depression. Contemporary Clinical Trials 36, 616623.
Steyerberg, EW, Vedder, MM, Leening, MJ, Postmus, D, D'Agostino, RB Sr., Van Calster, B, Pencina, MJ (2014). Graphical assessment of incremental value of novel markers in prediction models: from statistical to decision analytical perspectives. Biometrical Journal. Biometrische Zeitschrift.
Strobl, C, Malley, J, Tutz, G (2009). An introduction to recursive partitioning: rationale, application, and characteristics of classification and regression trees, bagging, and random forests. Psychological Methods 14, 323348.
Suarez, D, Haro, JM, Novick, D, Ochoa, S (2008). Marginal structural models might overcome confounding when analyzing multiple treatment effects in observational studies. Journal of Clinical Epidemiology 61, 525530.
Sung, SC, Haley, CL, Wisniewski, SR, Fava, M, Nierenberg, AA, Warden, D, Morris, DW, Kurian, BT, Trivedi, MH, Rush, AJ (2012). The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations. The Journal of Clinical Psychiatry 73, 967976.
Szadoczky, E, Rozsa, S, Zambori, J, Furedi, J (2004). Predictors for 2-year outcome of major depressive episode. Journal of Affective Disorders 83, 4957.
Tchetgen Tchetgen, E (2014). The control outcome calibration approach for causal inference with unobserved confounding. American Journal of Epidemiology 179, 633640.
Thase, ME, Reynolds, CF III, Frank, E, Simons, AD, McGeary, J, Fasiczka, AL, Garamoni, GG, Jennings, JR, Kupfer, DJ (1994). Do depressed men and women respond similarly to cognitive behavior therapy? The American Journal of Psychiatry 151, 500505.
Thase, ME, Greenhouse, JB, Frank, E, Reynolds, CF III, Pilkonis, PA, Hurley, K, Grochocinski, V, Kupfer, DJ (1997). Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Archives of General Psychiatry 54, 10091015.
Thase, ME, Pritchett, YL, Ossanna, MJ, Swindle, RW, Xu, J, Detke, MJ (2007). Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder. Journal of Clinical Psychopharmacology 27, 672676.
Toh, S, Manson, JE (2013). An analytic framework for aligning observational and randomized trial data: application to postmenopausal hormone therapy and coronary heart disease. Statistics in Biosciences 5.
Trivedi, MH, Morris, DW, Pan, JY, Grannemann, BD, John Rush, A (2005). What moderator characteristics are associated with better prognosis for depression? Neuropsychiatric Disease and Treatment 1, 5157.
Trivedi, MH, Rush, AJ, Wisniewski, SR, Nierenberg, AA, Warden, D, Ritz, L, Norquist, G, Howland, RH, Lebowitz, B, McGrath, PJ, Shores-Wilson, K, Biggs, MM, Balasubramani, GK, Fava, M (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. The American Journal of Psychiatry 163, 2840.
Troxel, WM, Kupfer, DJ, Reynolds, CF III, Frank, E, Thase, ME, Miewald, JM, Buysse, DJ (2012). Insomnia and objectively measured sleep disturbances predict treatment outcome in depressed patients treated with psychotherapy or psychotherapy-pharmacotherapy combinations. The Journal of Clinical Psychiatry 73, 478485.
Uher, R, Perroud, N, Ng, MY, Hauser, J, Henigsberg, N, Maier, W, Mors, O, Placentino, A, Rietschel, M, Souery, D, Zagar, T, Czerski, PM, Jerman, B, Larsen, ER, Schulze, TG, Zobel, A, Cohen-Woods, S, Pirlo, K, Butler, AW, Muglia, P, Barnes, MR, Lathrop, M, Farmer, A, Breen, G, Aitchison, KJ, Craig, I, Lewis, CM, McGuffin, P (2010). Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. The American Journal of Psychiatry 167, 555564.
Uher, R, Dernovsek, MZ, Mors, O, Hauser, J, Souery, D, Zobel, A, Maier, W, Henigsberg, N, Kalember, P, Rietschel, M, Placentino, A, Mendlewicz, J, Aitchison, KJ, McGuffin, P, Farmer, A (2011). Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline. Journal of Affective Disorders 132, 112120.
Upstill-Goddard, R, Eccles, D, Fliege, J, Collins, A (2013). Machine learning approaches for the discovery of gene-gene interactions in disease data. Briefings in Bioinformatics 14, 251260.
van der Laan, MJ, Gruber, S (2010). Collaborative double robust targeted maximum likelihood estimation. The International Journal of Biostatistics 6, Article 17.
van der Laan, MJ, Rose, S (2011). Targeted Learning: Causal Inference for Observational and Experimental Data. Springer: New York.
van Loo, HM, de Jonge, P, Romeijn, JW, Kessler, RC, Schoevers, RA (2012). Data-driven subtypes of major depressive disorder: a systematic review. BMC Medicine 10, 156.
van Loo, HM, Cai, T, Gruber, MJ, Li, J, de Jonge, P, Petukhova, M, Rose, S, Sampson, NA, Schoevers, RA, Wardenaar, KJ, Wilcox, MA, Al-Hamzawi, AO, Andrade, LH, Bromet, EJ, Bunting, B, Fayyad, J, Florescu, SE, Gureje, O, Hu, C, Huang, Y, Levinson, D, Medina-Mora, ME, Nakane, Y, Posada-Villa, J, Scott, KM, Xavier, M, Zarkov, Z, Kessler, RC (2014). Major depressive disorder subtypes to predict long-term course. Depression and Anxiety 31, 765777.
Van Staa, TP, Goldacre, B, Gulliford, M, Cassell, J, Pirmohamed, M, Taweel, A, Delaney, B, Smeeth, L (2012). Pragmatic randomised trials using routine electronic health records: putting them to the test. BMJ 344.
Vrieze, E, Demyttenaere, K, Bruffaerts, R, Hermans, D, Pizzagalli, DA, Sienaert, P, Hompes, T, de Boer, P, Schmidt, M, Claes, S (2014). Dimensions in major depressive disorder and their relevance for treatment outcome. Journal of Affective Disorders 155, 3541.
Vuorilehto, MS, Melartin, TK, Isometsa, ET (2009). Course and outcome of depressive disorders in primary care: a prospective 18-month study. Psychological Medicine 39, 16971707.
Wallace, ML, Frank, E, Kraemer, HC (2013). A novel approach for developing and interpreting treatment moderator profiles in randomized clinical trials. JAMA Psychiatry 70, 12411247.
Wardenaar, KJ, van Loo, HM, Cai, T, Fava, M, Gruber, MJ, Li, J, de Jonge, P, Nierenberg, AA, Petukhova, MV, Rose, S, Sampson, NA, Schoevers, RA, Wilcox, MA, Alonso, J, Bromet, EJ, Bunting, B, Florescu, SE, Fukao, A, Gureje, O, Hu, C, Huang, YQ, Karam, AN, Levinson, D, Medina Mora, ME, Posada-Villa, J, Scott, KM, Taib, NI, Viana, MC, Xavier, M, Zarkov, Z, Kessler, RC (2014). The effects of co-morbidity in defining major depression subtypes associated with long-term course and severity. Psychological Medicine 44, 32893302.
Williams, LM, Rush, AJ, Koslow, SH, Wisniewski, SR, Cooper, NJ, Nemeroff, CB, Schatzberg, AF, Gordon, E (2011). International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol. Trials 12, 4.
Willke, RJ, Zheng, Z, Subedi, P, Althin, R, Mullins, CD (2012). From concepts, theory, and evidence of heterogeneity of treatment effects to methodological approaches: a primer. BMC Medical Research Methodology 12, 185.
Zhang, H, Singer, BH (2010). Recursive Partitioning and Applications. Springer: New York.


Related content

Powered by UNSILO

Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder

  • R. C. Kessler (a1), H. M. van Loo (a2), K. J. Wardenaar (a2), R. M. Bossarte (a3), L. A. Brenner (a4), D. D Ebert (a1) (a5), P. de Jonge (a2), A. A. Nierenberg (a6), A. J. Rosellini (a1), N. A. Sampson (a1), R. A. Schoevers (a2), M. A. Wilcox (a7) and A. M. Zaslavsky (a1)...


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.